BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 26021267)

  • 1. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKT/GSK-3β regulates stability and transcription of snail which is crucial for bFGF-induced epithelial-mesenchymal transition of prostate cancer cells.
    Liu ZC; Wang HS; Zhang G; Liu H; Chen XH; Zhang F; Chen DY; Cai SH; Du J
    Biochim Biophys Acta; 2014 Oct; 1840(10):3096-105. PubMed ID: 25088797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3 mediates TGF-β1-induced TWIST1 expression and prostate cancer invasion.
    Cho KH; Jeong KJ; Shin SC; Kang J; Park CG; Lee HY
    Cancer Lett; 2013 Aug; 336(1):167-73. PubMed ID: 23623921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
    Kim CJ; Sakamoto K; Tambe Y; Inoue H
    Int J Oncol; 2011 Jun; 38(6):1759-66. PubMed ID: 21468544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
    Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
    Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of Snail through AKT/GSK-3β signaling pathway is required for TNF-α-induced epithelial-mesenchymal transition in prostate cancer PC3 cells.
    Wang H; Fang R; Wang XF; Zhang F; Chen DY; Zhou B; Wang HS; Cai SH; Du J
    Eur J Pharmacol; 2013 Aug; 714(1-3):48-55. PubMed ID: 23769744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.
    Gajula RP; Chettiar ST; Williams RD; Nugent K; Kato Y; Wang H; Malek R; Taparra K; Cades J; Annadanam A; Yoon AR; Fertig E; Firulli BA; Mazzacurati L; Burns TF; Firulli AB; An SS; Tran PT
    Neoplasia; 2015 Jan; 17(1):16-31. PubMed ID: 25622896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
    Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
    Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT; Morton D; Komaragiri S; Millena AC; Leath C; Khan SA
    Endocrinology; 2013 May; 154(5):1768-79. PubMed ID: 23515290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
    Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
    Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt2 mediates TGF-β1-induced epithelial to mesenchymal transition by deactivating GSK3β/snail signaling pathway in renal tubular epithelial cells.
    Lan A; Qi Y; Du J
    Cell Physiol Biochem; 2014; 34(2):368-82. PubMed ID: 25059120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin: a promising target of therapeutical intervention for prostate cancer.
    Sun C; Zhao X; Xu K; Gong J; Liu W; Ding W; Gou Y; Xia G; Ding Q
    J Transl Med; 2011 Jun; 9():99. PubMed ID: 21714934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.